Sheila Mikhail

Jurata Thin Film, Inc. is a privately-held biotechnology company located in the US that aims to revolutionize the manufacturing, storage, distribution, and delivery of vaccines and biologics. The American company's technology has been proven to protect cargo even when exposed to extreme temperatures, potentially removing the need for cold chain logistics in vaccine and biologic transport and storage. Jurata's thin films have the potential to store therapeutics at room temperature for up to three years prior to reconstitution and up to eight months after reconstitution while maintaining therapeutic payload potency.

The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC.

InnerOptic Technology, Inc. develops real-time visualization systems. Its services include integration, contract development, and patent licensing. The firm specializes in laparoscopy and laparoscopic ultrasound, image-guided surgery, medical visualization, real-time tracking and spatial coordination, 3D navigation, and human perception, factors, and computer interaction. The company was founded by Kurtis P. Keller, Sheila A. Mikhail, Andrei State, and Henry Fuchs in 2003 and is headquartered in Hillsborough, NC.

American Bar Association provides legal services. It provides law school accreditation, continuing legal education, legal information and other services to assist legal professionals. The firm has members which include judges, court administrators, law professors, and non-practicing attorneys. The company was founded on August 21, 1878 and is headquartered in Chicago, IL.

Viralgen Vector Core SL is a contract development and manufacturing organization (CDMO) that produces AAV gene therapy treatments for pharmaceutical and biotech companies. The company was founded in 2017 by Javier García Cogorro and is based in Donostia-San Sebastian, Spain. Viralgen offers the Pro10™ based suspension manufacturing platform, which increases scalability, performance, and yield of AAV therapies. The Spanish company's clinical facilities have four CGMP manufacturing suites, with 250-liter and 500-liter bioreactors. In 2020, Viralgen expanded within the scientific park by constructing a new building for large-scale commercial manufacturing. The new state-of-the-art space includes three additional CGMP suites with a manufacturing capacity of >2,000 liters each, as well as a suite dedicated to fully automated fill and finish operations. The new facility has received the CGMP certification by the Spanish Agency for Medicines and Medical Devices (AEMPS) as part of the EMA network. The CEO is Jimmy Vanhove.

Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC.